CN1285573C - 3－脱氧－维生素d3类似物酯 - Google Patents

3－脱氧－维生素d3类似物酯 Download PDF

Info

Publication number
CN1285573C
CN1285573C CNB028185285A CN02818528A CN1285573C CN 1285573 C CN1285573 C CN 1285573C CN B028185285 A CNB028185285 A CN B028185285A CN 02818528 A CN02818528 A CN 02818528A CN 1285573 C CN1285573 C CN 1285573C
Authority
CN
China
Prior art keywords
compound
structural formula
group
following
acyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028185285A
Other languages
English (en)
Chinese (zh)
Other versions
CN1556795A (zh
Inventor
米兰·罗多耶·乌斯科科维奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1556795A publication Critical patent/CN1556795A/zh
Application granted granted Critical
Publication of CN1285573C publication Critical patent/CN1285573C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB028185285A 2001-09-21 2002-09-12 3－脱氧－维生素d3类似物酯 Expired - Fee Related CN1285573C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32387001P 2001-09-21 2001-09-21
US32395701P 2001-09-21 2001-09-21
US60/323,957 2001-09-21
US60/323,870 2001-09-21

Publications (2)

Publication Number Publication Date
CN1556795A CN1556795A (zh) 2004-12-22
CN1285573C true CN1285573C (zh) 2006-11-22

Family

ID=26984180

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028185285A Expired - Fee Related CN1285573C (zh) 2001-09-21 2002-09-12 3－脱氧－维生素d3类似物酯

Country Status (14)

Country Link
EP (1) EP1430026A1 (ru)
JP (1) JP2005503434A (ru)
KR (1) KR100628586B1 (ru)
CN (1) CN1285573C (ru)
AU (1) AU2002338672B2 (ru)
BR (1) BR0212719A (ru)
CA (1) CA2459789A1 (ru)
MX (1) MXPA04002640A (ru)
PA (1) PA8554901A1 (ru)
PE (1) PE20030429A1 (ru)
PL (1) PL370352A1 (ru)
RU (1) RU2296121C2 (ru)
UY (1) UY27448A1 (ru)
WO (1) WO2003027065A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL376148A1 (en) * 2002-10-23 2005-12-27 Leo Pharma A/S Vitamin d analogues, compositions comprising said analogues and their use
AU2005289664A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
CN102124301B (zh) 2008-08-22 2014-04-02 Nxp股份有限公司 基于位置的服务
CN110339205B (zh) * 2019-08-19 2021-08-24 山东德信生物科技有限公司 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs

Also Published As

Publication number Publication date
PA8554901A1 (es) 2003-12-10
JP2005503434A (ja) 2005-02-03
BR0212719A (pt) 2004-08-03
PE20030429A1 (es) 2003-05-15
RU2296121C2 (ru) 2007-03-27
CA2459789A1 (en) 2003-04-03
AU2002338672B2 (en) 2006-03-09
PL370352A1 (en) 2005-05-16
MXPA04002640A (es) 2004-06-07
CN1556795A (zh) 2004-12-22
UY27448A1 (es) 2003-03-31
WO2003027065A1 (en) 2003-04-03
RU2004112217A (ru) 2005-07-10
EP1430026A1 (en) 2004-06-23
KR100628586B1 (ko) 2006-09-26
KR20040035853A (ko) 2004-04-29

Similar Documents

Publication Publication Date Title
CN1048986C (zh) 杂环化合物及其制备和用途
CN1108289C (zh) 二氟前列腺素衍生物及其使用
CN1077574C (zh) 托烷衍生物,其制备和应用
CN1290819C (zh) 2－氨基丙烷－1，3－二醇化合物、其作为医药的用途及其合成中间体
CN1042026C (zh) 维生素d系列的25羧酸衍生物、其制法及中间产物、含该衍生物的药物及其药用
CN1020093C (zh) 1-苯基-3-萘氧基丙胺的制备方法
CN1582277A (zh) 用作糖原合酶激酶3β抑制剂的酰胺衍生物
CN1019113B (zh) 3-芳氢基-3-取代的丙胺的制法
CN1161035A (zh) 降血脂1，4-苯并氮杂䓬-1，1-二氧化物
CN87107371A (zh) 螺-取代的戊二酰胺利尿剂
CN1168631A (zh) 治疗抗性肿瘤的方法
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1612852A (zh) 脂氧素a4类似物
CN100347158C (zh) 二环化合物
CN1671643A (zh) 双极性反式类胡萝卜素盐及其应用
CN1372543A (zh) 在侧链中具有环状结构的新维生素d衍生物、其制备方法和中间产物、以及在制备药物中的应用
CN1217926C (zh) 新的维生素d类似物
CN1214022C (zh) 维他命d类似物
CN1031262C (zh) 环取代的2-氨基-1，2，3，4-四氢化萘和3-氨基苯并二氢吡喃
CN1310900C (zh) 双芳基化合物和含有它们的药物和化妆品组合物
CN1031532A (zh) 杂环化合物
CN1285573C (zh) 3－脱氧－维生素d3类似物酯
CN86106294A (zh) 二氢吡啶类的制备方法
CN1013442B (zh) 新双环化合物的制备方法
CN1852720A (zh) 包含2－亚烷基－19－去甲－维生素d衍生物与雌激素激动剂/拮抗剂的组合的药物组合物和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee